These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10466489)

  • 1. Electrical restitution, critical mass, and the riddle of fibrillation.
    Gilmour RF; Chialvo DR
    J Cardiovasc Electrophysiol; 1999 Aug; 10(8):1087-9. PubMed ID: 10466489
    [No Abstract]   [Full Text] [Related]  

  • 2. Relation between cellular repolarization characteristics and critical mass for human ventricular fibrillation.
    Wu TJ; Yashima M; Doshi R; Kim YH; Athill CA; Ong JJ; Czer L; Trento A; Blanche C; Kass RM; Garfinkel A; Weiss JN; Fishbein MC; Karagueuzian HS; Chen PS
    J Cardiovasc Electrophysiol; 1999 Aug; 10(8):1077-86. PubMed ID: 10466488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of antidysrhythmic and analgesic drugs on haemodynamics and fibrillatory threshold.
    Rashid S
    J Pak Med Assoc; 1981 Jul; 31(7):141-5. PubMed ID: 6792395
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiac vulnerability.
    Surawicz B; Steffens T
    Cardiovasc Clin; 1973; 5(3):159-81. PubMed ID: 4601967
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis and antifibrillatory activity of nibentan and its analogues.
    Davydova NK; Sizova OS; Vinogradova SM; L'vov AI; Glushkov RG; Yuzhakov SD; Mashkovskiy MD
    Eur J Med Chem; 2000 Feb; 35(2):205-15. PubMed ID: 10758282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of heart mass in the spontaneous defibrillation process].
    Kobrin VI; Ignatova EE; Vostrikov VA
    Biull Eksp Biol Med; 1991 Oct; 112(10):339-40. PubMed ID: 1804333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventing ventricular fibrillation by flattening cardiac restitution.
    Garfinkel A; Kim YH; Voroshilovsky O; Qu Z; Kil JR; Lee MH; Karagueuzian HS; Weiss JN; Chen PS
    Proc Natl Acad Sci U S A; 2000 May; 97(11):6061-6. PubMed ID: 10811880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ventricular fibrillation: how do we stop the waves from breaking?
    Weiss JN; Chen PS; Qu Z; Karagueuzian HS; Garfinkel A
    Circ Res; 2000 Dec; 87(12):1103-7. PubMed ID: 11110766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of KLN-93 on ventricular fibrillation induced by reperfusion or electrical stimulation in cats].
    Leonidov NB; Galenko-Iaroshevskiĭ PA; Fitilev SB; Kniazhev VA; Gatsura VV
    Biull Eksp Biol Med; 1997 Aug; 124(8):135-7. PubMed ID: 9410191
    [No Abstract]   [Full Text] [Related]  

  • 10. Organization of ventricular fibrillation in the human heart.
    Ten Tusscher KH; Hren R; Panfilov AV
    Circ Res; 2007 Jun; 100(12):e87-101. PubMed ID: 17540975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic restitution of action potential duration during electrical alternans and ventricular fibrillation.
    Koller ML; Riccio ML; Gilmour RF
    Am J Physiol; 1998 Nov; 275(5):H1635-42. PubMed ID: 9815071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide mediates the vagal protective effect on ventricular fibrillation via effects on action potential duration restitution in the rabbit heart.
    Brack KE; Patel VH; Coote JH; Ng GA
    J Physiol; 2007 Sep; 583(Pt 2):695-704. PubMed ID: 17627986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of ventricular fibrillation thresholds after sympatholytic drugs in the dog.
    Wellens D; Wauters E
    Arch Int Pharmacodyn Ther; 1972 Aug; 198(2):355-71. PubMed ID: 4403391
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug-induced J point elevation: a marker for genetic risk of sudden death or ECG curiosity?
    Roden DM; Wilde AA
    J Cardiovasc Electrophysiol; 1999 Feb; 10(2):219-23. PubMed ID: 10090225
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of befol on the threshold of electric fibrillation of heart ventricles].
    Galenko-Iaroshevskiĭ PA; Kryzhanovskiĭ SA; Vititnova MB; Khankoeva AI
    Biull Eksp Biol Med; 1997 Mar; 123(3):305-7. PubMed ID: 9162241
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of ventricular arrhythmias.
    Lancet; 1971 Oct; 2(7729):857-8. PubMed ID: 4106879
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanism of procainamide-induced prevention of spontaneous wave break during ventricular fibrillation. Insight into the maintenance of fibrillation wave fronts.
    Kim YH; Yashima M; Wu TJ; Doshi R; Chen PS; Karagueuzian HS
    Circulation; 1999 Aug; 100(6):666-74. PubMed ID: 10441106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restitution, ventricular fibrillation, and drugs: where are we now?
    Strauss HC; Rasmusson RL
    J Cardiovasc Electrophysiol; 2002 Sep; 13(9):915-7. PubMed ID: 12380932
    [No Abstract]   [Full Text] [Related]  

  • 19. The distribution of refractory periods influences the dynamics of ventricular fibrillation.
    Choi BR; Liu T; Salama G
    Circ Res; 2001 Mar; 88(5):E49-58. PubMed ID: 11249880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-coupling premature ventricular complexes from the left ventricle triggered isoproterenol-resistant electrical storm in a patient with Brugada syndrome.
    Chinushi M; Iijima K; Sato A; Furushima H
    Heart Rhythm; 2013 Jun; 10(6):916-20. PubMed ID: 23333720
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.